Proinnovera GmbH
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Proinnovera GmbH - overview
Established
1997
Location
Munster, -, Germany
Primary Industry
Pharmaceuticals
About
Based in Muenster, Germany, and founded in 1997, Proinnovera GmbH operates as a contract research organization (CRO) that offers clinical trial executions. In November 2023, the firm merged with ARCHIMED and its portfolio companies and Symbio, LLC to form Symbio Proinnovera. The firm as of November 2023 has a database of more than 100,000 patients in over 4,500 sites, and is led by its CEO and founder, Burkhard Breuer. The company operates globally and offers full-service capabilities for clinical studies from Phase I to IV, including non-interventional and medical device studies across 40 countries.
Proinnovera specializes in dermatology, oncology, and inflammatory diseases. The company has conducted over 650 clinical studies, as of November 2023. Proinnovera's other clinical research services, include clinical monitoring, data management and biostatistics, feasibility and patient recruitment, medical writing, project management, and regulatory affairs.
Current Investors
ARCHIMED
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceutical Research & Development
Website
www.proinnovera.com/
Company Stage
Mature - Buyout
Total Amount Raised
Subscriber access only
Proinnovera GmbH - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Merger | Completed | Proinnovera GmbH, Symbio, LLC | - | ||||||||
| Buyout | Completed | Proinnovera GmbH | - |
Displaying 1 - 2 of 2
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.